Bellicum Pharmaceuticals Inc. (BLCM) declined -6.16% or -0.22 to $3.35. It is around 209428 shares traded, which is 34.33% compare to the average total volume 610027. The market cap of BLCM is $145.26 million. The year to date change is -5.56%. The 52 week price range is from $2.74 to $10.26. Price of BLCM have changed 0.85% during last week. It have changed -2.72% over last month, -31.61% over last 3 months, -55.21% over last 6 months and -57.80% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for BLCM is 3.94. It is 17.61% above current price. The 200-day Moving Averages for BLCM is 6.26. It is 86.87% above current price. The 52-week High is 10.26. It is 206.27% from the current price. The 52-week Low is 2.74. It is -18.21% from current price.
There are some statistics of BLCM. It is has market cap $145.26 million. The share outstanding is 43.36 million. The average volume is 610027. The percent of top 15 Institution holding is 85.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of BLCM is -94.83%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of BLCM is -63.57%.